The 16 linked references in paper K. Mukhin Yu., O. Pylaeva A., A. Dolinina F., S. Moiseeva, Yu. Verbitskaya V., A. Petrukhin S., G. Kluger, H. Holthausen, M. Staudt, К. Мухин Ю., О. Пылаева А., А. Долинина Ф., С. Моисеева, Ю. Вербицкая В., А. Петрухин С., Г. Клюгер, Х. Хольтхаузен, М. Штаудт (2016) “ЭПИЛЕПСИЯ, ВЫЗВАННАЯ МУТАЦИЕЙ ГЕНА PCDH19: ОБЗОР ЛИТЕРАТУРЫ И СОБСТВЕННЫЕ НАБЛЮДЕНИЯ // EPILEPSY CAUSED BY PCDH19 GENE MUTATION: A REVIEW OF LITERATURE AND THE AUTHORS’ OBSERVATIONS” / spz:neicon:rjdn:y:2016:i:2:p:26-32

  1. Мухин К.Ю., Пылаева О.А., Миронов М.Б. и др. Электроэнцефалографические изменения при синдроме Драве. Русский журнал детской неврологии 2014;9(4):6–13. [Mukhin K.Yu., Pylaeva O.A., Mironov M.B. et al. Electroencephalographic changes with Dravet syndrome. Russkiy zhurnal detskoy nevrologii = Russian Journal of Child Neurology 2014;9(4):6–13. (In Russ.)]. DOI: 10.17650/2073-8803-2014-9-4-6-13.
  2. Jonghe P. Molecular genetics of Dravet syndrome. Dev Med Child Neurol 2011; 53 Suppl 2:7–10. DOI: 10.1111/j.1469-8749.2011.03965.x.
  3. Depienne C., Bouteiller D., Keren B. et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet 2009;5(2):e1000381. DOI: 10.1371/journal.pgen.1000381.
  4. Depienne C., Trouillard O., Bouteiller D. et al. Mutations and deletions in PCDH19 account for various familial or isolated epilepsies in females. Hum Mutat 2011;32(1):E1959–75. DOI: 10.1002/humu.21373.
  5. Dibbens L.M., Tarpey P.S., Hynes K. et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet 2008;40(6):776–81. DOI: 10.1038/ng.149.
  6. Gagliardi M., Annesi G., Sesta M. et al. PCDH19 mutations in female patients from Southern Italy. Seizure 2015;24:118–20. DOI: 10.1016/j.seizure.2014.08.010.
  7. Higurashi N., Nakamura M., Sugai M. et al. PCDH19-related female-limited epilepsy: further details regarding early clinical features and therapeutic efficacy. Epilepsy Res 2013;106(1–2):191–9. DOI: 10.1016/j.eplepsyres.2013.04.005.
  8. Higurashi N., Takahashi Y., Kashimada A. et al. Immediate suppression of seizure clusters by corticosteroids in PCDH19 female epilepsy. Seizure 2015;27:1–5. DOI: 10.1016/j.seizure.2015.02.006.
  9. Kwong A.K., Fung C.W., Chan S.Y., Wong V.C. Identification of SCN1A and PCDH19 mutations in Chinese children with Dravet syndrome. PLoS One 2012;7(7):e41802. DOI: 10.1371/journal.pone.0041802.
  10. Lotte J., Bast T., Borusiak P. et al. Effectiveness of antiepileptic therapy in patients with PCDH19 mutations. Seizure 2016;35:106–10. DOI: 10.1016/j.seizure.2016.01.006.
  11. Marini C., Mei D., Parmeggiani L. et al. Protocadherin 19 mutations in girls with infantile-onset epilepsy. Neurology 2010;75(7):646–53. DOI: 10.1212/ WNL.0b013e3181ed9e67.
  12. Nicita F., De Liso P., Danti F.R. et al. The genetics of monogenic idiopathic epilepsies and epileptic encephalopathies. Seizure 2012;21(1):3–11. DOI: 10.1016/j.seizure.2011.08.007.
  13. Ryan S.G., Chance P.F., Zou C.H. et al. Epilepsy and mental retardation limited to females: an X-linked dominant disorder with male sparing. Nat Genet 1997;17(1):92– 5. DOI: 10.1038/ng0997-92.
  14. Scheffer I.E., Turner S.J., Dibbens L.M. et al. Epilepsy and mental retardation limited to females: an under-recognized disorder. Brain 2008;131(Pt 4):918–27. DOI: 10.1093/brain/awm338.
  15. Trivisano M., Specchio N., Vigevano F. Extending the use of stiripentol to other epileptic syndromes: a case of PCDH19-related epilepsy. Eur J Paediatr Neurol 2015;19(2):248–50. DOI: 10.1016/j. ejpn.2014.11.008.
  16. Wallace A., Wirrell E., Kenney-Jung D.L. Pharmacotherapy for Dravet syndrome. Paediatr Drugs 2016;18(3):197–208. DOI: 10.1007/s40272-016-0171-7.